BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 32051587)

  • 1. Loss of p53 drives neuron reprogramming in head and neck cancer.
    Amit M; Takahashi H; Dragomir MP; Lindemann A; Gleber-Netto FO; Pickering CR; Anfossi S; Osman AA; Cai Y; Wang R; Knutsen E; Shimizu M; Ivan C; Rao X; Wang J; Silverman DA; Tam S; Zhao M; Caulin C; Zinger A; Tasciotti E; Dougherty PM; El-Naggar A; Calin GA; Myers JN
    Nature; 2020 Feb; 578(7795):449-454. PubMed ID: 32051587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Head and neck cancer exosomes drive microRNA-mediated reprogramming of local neurons.
    Hunt PJ; Amit M
    Extracell Vesicles Circ Nucl Acids; 2020; 1():57-62. PubMed ID: 33554224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interplay between cancer cells and M2 macrophages is necessary for miR-550a-3-5p down-regulation-mediated HPV-positive OSCC progression.
    Cao MX; Zhang WL; Yu XH; Wu JS; Qiao XW; Huang MC; Wang K; Wu JB; Tang YJ; Jiang J; Liang XH; Tang YL
    J Exp Clin Cancer Res; 2020 Jun; 39(1):102. PubMed ID: 32493454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disruption of TP63-miR-27a* Feedback Loop by Mutant TP53 in Head and Neck Cancer.
    Chari NS; Ivan C; Le X; Li J; Mijiti A; Patel AA; Osman AA; Peterson CB; Williams MD; Pickering CR; Caulin C; Myers JN; Calin GA; Lai SY
    J Natl Cancer Inst; 2020 Mar; 112(3):266-277. PubMed ID: 31124563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neural reprogramming via microRNAs: the new kid on the p53-deficient block.
    Silverman DA; Calin GA; Myers JN; Amit M
    Mol Cell Oncol; 2020; 7(4):1756723. PubMed ID: 32944617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer-Associated Neurogenesis and Nerve-Cancer Cross-talk.
    Silverman DA; Martinez VK; Dougherty PM; Myers JN; Calin GA; Amit M
    Cancer Res; 2021 Mar; 81(6):1431-1440. PubMed ID: 33334813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ablation of sensory nerves favours melanoma progression.
    Prazeres PHDM; Leonel C; Silva WN; Rocha BGS; Santos GSP; Costa AC; Picoli CC; Sena IFG; Gonçalves WA; Vieira MS; Costa PAC; Campos LMCC; Lopes MTP; Costa MR; Resende RR; Cunha TM; Mintz A; Birbrair A
    J Cell Mol Med; 2020 Sep; 24(17):9574-9589. PubMed ID: 32691511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer-associated fibroblasts contribute to oral cancer cells proliferation and metastasis via exosome-mediated paracrine miR-34a-5p.
    Li YY; Tao YW; Gao S; Li P; Zheng JM; Zhang SE; Liang J; Zhang Y
    EBioMedicine; 2018 Oct; 36():209-220. PubMed ID: 30243489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-1258, regulated by c-Myb, inhibits growth and epithelial-to-mesenchymal transition phenotype via targeting SP1 in oral squamous cell carcinoma.
    Zhang H; Jiang S; Guo L; Li X
    J Cell Mol Med; 2019 Apr; 23(4):2813-2821. PubMed ID: 30734471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TRIM8 restores p53 tumour suppressor function by blunting N-MYC activity in chemo-resistant tumours.
    Mastropasqua F; Marzano F; Valletti A; Aiello I; Di Tullio G; Morgano A; Liuni S; Ranieri E; Guerrini L; Gasparre G; Sbisà E; Pesole G; Moschetta A; Caratozzolo MF; Tullo A
    Mol Cancer; 2017 Mar; 16(1):67. PubMed ID: 28327152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exosomal microRNAs derived from colon cancer cells promote tumor progression by suppressing fibroblast TP53 expression.
    Yoshii S; Hayashi Y; Iijima H; Inoue T; Kimura K; Sakatani A; Nagai K; Fujinaga T; Hiyama S; Kodama T; Shinzaki S; Tsujii Y; Watabe K; Takehara T
    Cancer Sci; 2019 Aug; 110(8):2396-2407. PubMed ID: 31148360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down Regulation of miR-34a and miR-143 May Indirectly Inhibit p53 in Oral Squamous Cell Carcinoma: a Pilot Study.
    Manikandan M; Deva Magendhra Rao AK; Arunkumar G; Rajkumar KS; Rajaraman R; Munirajan AK
    Asian Pac J Cancer Prev; 2015; 16(17):7619-25. PubMed ID: 26625772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of miR-204 enables oral squamous cell carcinomas to promote cancer stemness, EMT traits, and lymph node metastasis.
    Yu CC; Chen PN; Peng CY; Yu CH; Chou MY
    Oncotarget; 2016 Apr; 7(15):20180-92. PubMed ID: 26933999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of α2- and β2-adrenoceptors on breast cancer cell proliferation and tumour growth regulation.
    Pérez Piñero C; Bruzzone A; Sarappa MG; Castillo LF; Lüthy IA
    Br J Pharmacol; 2012 May; 166(2):721-36. PubMed ID: 22122228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nerve growth factor links oral cancer progression, pain, and cachexia.
    Ye Y; Dang D; Zhang J; Viet CT; Lam DK; Dolan JC; Gibbs JL; Schmidt BL
    Mol Cancer Ther; 2011 Sep; 10(9):1667-76. PubMed ID: 21750223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A NOTCH feed-forward loop drives reprogramming from adrenergic to mesenchymal state in neuroblastoma.
    van Groningen T; Akogul N; Westerhout EM; Chan A; Hasselt NE; Zwijnenburg DA; Broekmans M; Stroeken P; Haneveld F; Hooijer GKJ; Savci-Heijink CD; Lakeman A; Volckmann R; van Sluis P; Valentijn LJ; Koster J; Versteeg R; van Nes J
    Nat Commun; 2019 Apr; 10(1):1530. PubMed ID: 30948783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-155 Inhibitor-Laden Exosomes Reverse Resistance to Cisplatin in a 3D Tumor Spheroid and Xenograft Model of Oral Cancer.
    Sayyed AA; Gondaliya P; Mali M; Pawar A; Bhat P; Khairnar A; Arya N; Kalia K
    Mol Pharm; 2021 Aug; 18(8):3010-3025. PubMed ID: 34176265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-34a inhibits oral cancer progression partially by repression of interleukin-6-receptor.
    Li T; Li L; Li D; Wang S; Sun J
    Int J Clin Exp Pathol; 2015; 8(2):1364-73. PubMed ID: 25973020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA HNF1A-AS1 mediated repression of miR-34a/SIRT1/p53 feedback loop promotes the metastatic progression of colon cancer by functioning as a competing endogenous RNA.
    Fang C; Qiu S; Sun F; Li W; Wang Z; Yue B; Wu X; Yan D
    Cancer Lett; 2017 Dec; 410():50-62. PubMed ID: 28943452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression.
    Fang Z; Zhao J; Xie W; Sun Q; Wang H; Qiao B
    Cancer Med; 2017 Dec; 6(12):2897-2908. PubMed ID: 29125238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.